Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director comp. Appointed COO
|
Jasper Therapeutics, Inc. (AMHCU)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/26/2023 |
4
| CROSS HERB (CFO) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 550,000 options to buy
@ $0.78, valued at
$429k
|
|
06/08/2023 |
4
| Kapoor Vishal (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
06/08/2023 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
06/08/2023 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
06/08/2023 |
4
| Shizuru Judith Anne (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
06/08/2023 |
4
| Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
06/08/2023 |
4
| Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
06/08/2023 |
4
| French Anna Louise (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/20/2023 |
4
| MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 500,000 options to buy
@ $1.87, valued at
$935k
|
|
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2023 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Sold 75,000 shares
@ $1.89, valued at
$141.8k
|
|
10/13/2022 |
4
| MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 506,250 shares
@ $0 |
|
10/13/2022 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 24,500 shares
@ $0 |
|
10/13/2022 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 30,250 shares
@ $0 |
|
10/13/2022 |
4
| Shizuru Judith Anne (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 29,500 shares
@ $0 |
|
10/13/2022 |
4
| Mahal Jeetinder Singh (See Remarks) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 214,722 shares
@ $0 |
|
10/13/2022 |
4
| Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 32,500 shares
@ $0 |
|
10/13/2022 |
4
| Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 29,500 shares
@ $0 |
|
10/13/2022 |
4
| French Anna Louise (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 30,750 shares
@ $0 |
|
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2022 |
4
| Mahal Jeetinder Singh (See Remarks) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 48,441 options to buy
@ $3.12, valued at
$151.1k
|
|
03/23/2022 |
4
| MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 1,704,328 options to buy
@ $3.54, valued at
$6M
|
|
03/23/2022 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 78,045 options to buy
@ $3.54, valued at
$276.3k
|
|
03/23/2022 |
4
| EMSTER KURT VON (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns:
| Granted 78,045 options to buy
@ $3.54, valued at
$276.3k
|
|
|
|
|